アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。

私たちはウェブサイトをできるだけ使いやすくするために、クッキーを使用しています。

クッキー・ポリシーでは、使用するクッキーをオプトアウトする方法について説明しています。

クッキーの設定を変更しないままでいる場合、このポリシーに同意しているとみなされます。

続ける 続ける

お問い合わせは電話 +81-(0)3-6231-0940 または メールでどうぞ

  • アカウント
  • ログアウト
ログイン または 新規登録

Welcome

ログイン または

すでにアカウントをお持ちですか?

新規登録
カート
クイック・オーダー
Abcam homepage

  • 研究用製品
    製品タイプ別
    一次抗体
    二次抗体
    イムノアッセイキット・試薬
    細胞・組織イメージング
    細胞・バイオケミカルアッセイ
    タンパク質・ペプチド
    製品タイプ別
    プロテオミクス
    アゴニスト・アクチベータ-・アンタゴニスト・インヒビター
    細胞株・ライゼート
    miRNA マルチプレックス・アッセイキット
    マルチプレックス・アッセイ
    研究分野別
    癌
    循環器系
    細胞生物学
    エピジェネティクス
    メタボリズム
    発生生物学
    研究分野別
    免疫学
    微生物学
    脳神経科学
    シグナル伝達
    ステムセル
  • 診断と治療のソリューション
    カスタム・ソリューション & パートナーシップ

    あなたの診断法や治療法を発展させるための、カスタム抗体開発およびコマーシャル・パートナーシップ

    私たちと共にカスタム・ソリューションを創造する

    私たちとパートナーになる

  • サポート
    サポートハブ

    研究のためのサポートとアドバイス

    サポートハブを表示

    プロトコール

    実験のステップごとの詳細

    プロトコールを表示

  • イベント
    • イベント・カレンダー
    • 癌
    • 循環器
    • エピジェネティクス&核内情報
    • 免疫学
    • ニューロサイエンス
    • ステムセル
    • 展示会
    • ウェビナー
    最新のイベント情報

    世界中でアブカムが主催する研究会やセミナーの日程、内容、演者など

    イベント・カレンダー

  • パスウェイ
    細胞シグナル伝達パスウェイ

    すべてのパスウェイを見る

    インタラクティブ・パスウェイを見る

  • ブログ
    アブカム・ブログ

    最新の情報はこちら.

    • キャンペーン
    • 製品情報
    • 技術情報

新型コロナウイルス (COVID-19)に伴う当社の対応について

  1. Link

    fgfr1-alpha-antibody-m2f12-ab829.pdf

  1. Send me a copy of this email
    I agree to the terms and conditions.
Cardiovascular Angiogenesis Growth Factors FGF FGF Receptors
Share by email

Anti-FGFR1 alpha 抗体 [M2F12] (ab829)

  • Datasheet
  • SDS
Reviews (2)Q&A (3)References (12)

Product price, shipping and contact information

Currently unavailable

申し訳ございませんが、現在表示できません。

こちらにお問い合わせいただくか、またはしばらく経ってから改めてお試しください

 

Loading size & price…

 

出荷および受注について

Abpromise

保証された製品品質、優れたカスタマー・サポート。 詳細はこちら。

Immunocytochemistry/ Immunofluorescence - Anti-FGFR1 alpha antibody [M2F12] (ab829)

    Key features and details

    • Mouse monoclonal [M2F12] to FGFR1 alpha
    • Suitable for: ICC/IF
    • Reacts with: Human
    • Isotype: IgG2a

    こちらの製品もご検討ください

    一次抗体
    Product image
    Anti-FGFR2 antibody (ab10648)
    一次抗体
    Product image
    Anti-AKT1 + AKT2 + AKT3 (phospho S472 + S473 + S474) antibody [EPR18853] (ab192623)
    二次抗体
    Product image
    Goat Anti-Mouse IgG H&L (HRP) (ab205719)

    関連製品

    製品の概要

    • 製品名

      Anti-FGFR1 alpha antibody [M2F12]
      FGFR1 alpha 一次抗体 製品一覧
    • 製品の詳細

      Mouse monoclonal [M2F12] to FGFR1 alpha
    • 由来種

      Mouse
    • 特異性

      Reacts with alpha isoform of FRFR1.
    • アプリケーション

      適用あり: ICC/IFmore details
    • 種交差性

      交差種: Human
    • 免疫原

      Recombinant human ectodomain of FGFr1a expressed in E. coli beginning with pro23; antigen contained NH2-terminal gly-ser-pro-gly-ile and COOH-terminal glu-phe sequences.

    • エピトープ

      NH2-terminus of unique NH2-terminal Ig loop of FGFr1. Epitope is within the sequence between glu30 and ala74 of FGFr1a.
    • ポジティブ・コントロール

      • IHC: Rat prostate tissue.
    • 特記事項

      This product was changed from ascites to tissue culture supernatant on 19/12/2018. Please note that the dilutions may need to be adjusted accordingly. If you have any questions please do not hesitate to contact our scientific support team.

      The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

      If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

    製品の特性

    • 製品の状態

      Liquid
    • 保存方法

      Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
    • バッファー

      pH: 7.40
      Constituent: PBS
    • Concentration information loading...
    • 精製度

      Protein G purified
    • 特記事項(精製)

      Purified from TCS
    • ポリ/モノ

      モノクローナル
    • クローン名

      M2F12
    • アイソタイプ

      IgG2a
    • 研究分野

      • Cardiovascular
      • Angiogenesis
      • Growth Factors
      • FGF
      • FGF Receptors
      • Signal Transduction
      • Growth Factors/Hormones
      • FGF
      • Cancer
      • Growth factors
      • FGF

    関連製品

    • Compatible Secondaries

      • Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) (ab150113)
      • Goat Anti-Mouse IgG H&L (HRP) (ab205719)
    • Isotype control

      • Mouse IgG2a, kappa monoclonal [MG2a-53] - Isotype control (ab18415)
    • Recombinant Protein

      • Recombinant human FGFR1 alpha protein (Fc Chimera) (ab55758)

    アプリケーション

    The Abpromise guarantee

    Abpromise保証は、 次のテスト済みアプリケーションにおけるab829の使用に適用されます

    アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。

    アプリケーション Abreviews 特記事項
    ICC/IF
    Use a concentration of 10 µg/ml.
    特記事項
    ICC/IF
    Use a concentration of 10 µg/ml.

    ターゲット情報

    • 関連性

      FGFR1 (fibroblast growth factor receptor 1) is a member of the fibroblast growth factor receptor family and contains an Ig-like domain and a tyrosine kinase domain. This receptor has multiple isoforms and is a Type I membrane protein. FGFR1 is widely expressed, with distinct isoforms expressed in specific tissues. FGFR1 binds fibroblast growth factor and induces mitogenesis and cellular differentiation. Defects in FGFR1 result in Pfeiffer syndrome associated with craniosynostosis. FGFR1 can be modified by phosphorylation and can bind basic/acidic fibroblast factor depending on the receptor isoform. FGFR1 has been shown to interact with N-cadherin and NCAM.
    • 細胞内局在

      Cell Membrane
    • 参照データベース

      • Entrez Gene: 2260 Human
      • Omim: 136350 Human
      • SwissProt: P11362 Human
      • Unigene: 264887 Human
      • 別名

        • BFGFR antibody
        • CD331 antibody
        • CEK antibody
        • FGFBR antibody
        • FGFR1 antibody
        • FLG antibody
        • FLT2 antibody
        • FMS like tyrosine kinase 2 antibody
        • HBGFR antibody
        • KAL2 antibody
        • N SAM antibody
        • OGD antibody
        see all

      画像

      • Immunocytochemistry/ Immunofluorescence - Anti-FGFR1 alpha antibody [M2F12] (ab829)
        Immunocytochemistry/ Immunofluorescence - Anti-FGFR1 alpha antibody [M2F12] (ab829)

        ICC/IF image of ab829 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab829, 10µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

        This image was generated using the ascites version of the product. 

      プロトコール

      • Immunocytochemistry & immunofluorescence protocols

      Click here to view the general protocols

      データシートおよび資料

      • SDS download

      • Datasheet download

        Download

      参考文献 (12)

      ab829 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

      ab829 は 12 報の論文で使用されています。

      • Formisano L  et al. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. Nat Commun 10:1373 (2019). PubMed: 30914635
      • Zhang GY  et al. Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo. PLoS One 14:e0212659 (2019). PubMed: 30925152
      • Voytyuk I  et al. BACE2 distribution in major brain cell types and identification of novel substrates. Life Sci Alliance 1:e201800026 (2018). PubMed: 30456346
      • Mao Y  et al. VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-ß play important roles in promoting immature and inflammatory intraplaque angiogenesis. PLoS One 13:e0201395 (2018). PubMed: 30125282
      • Nakamichi M  et al. Basic Fibroblast Growth Factor Induces Angiogenic Properties of Fibrocytes to Stimulate Vascular Formation during Wound Healing. Am J Pathol 186:3203-3216 (2016). PubMed: 27773739
      View all Publications for this product

      レビューと Q&A

      Show All レビュー Q&A
      レビューを送る 質問を送る

      1-5 of 5 Abreviews or Q&A

      Immunohistochemistry (Frozen sections) abreview for Anti-FGFR1 alpha antibody [M2F12]

      Good
      Abreviews
      Abreviews
      abreview image
      Application
      Immunohistochemistry (Frozen sections)
      Sample
      Human Tissue sections (Formalin Fixed Paraffin Embedded)
      Permeabilization
      No
      Specification
      Formalin Fixed Paraffin Embedded
      Fixative
      Formaldehyde
      Read More

      Abcam user community

      Verified customer

      投稿 Nov 12 2018

      Western blot abreview for Anti-FGFR1 alpha antibody [M2F12]

      Good
      Abreviews
      Abreviews
      abreview image
      Application
      Western blot
      Sample
      Mouse Tissue lysate - whole (Neuronal cells)
      Gel Running Conditions
      Non-reduced Denaturing (4-12%)
      Loading amount
      25 µg
      Specification
      Neuronal cells
      Blocking step
      Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
      Read More

      Abcam user community

      Verified customer

      投稿 Dec 19 2016

      Question

      Customer would like to know if this antibody binds to FGFR4 as well as FGFR1?

      Read More

      Abcam community

      Verified customer

      Asked on Jun 23 2004

      Answer

      No - this antibody is specific for FGFR1.

      Read More

      Abcam Scientific Support

      Answered on Jun 25 2004

      Question

      Concerning the epitope - does ab829 bind on the cell surface or on the inside?

      Read More

      Abcam community

      Verified customer

      Asked on Mar 29 2004

      Answer

      Ab829 binds on the cell surface.

      Read More

      Abcam Scientific Support

      Answered on Mar 30 2004

      Question

      I will try to answer all your questions below, and I also enclose pictures of staining results of frozen sections. Hope to hear from you. 1. Please describe the problem (high background, no staining etc).High background and weak signal from the antibody 2. On what material are you testing the antibody in IHC? Human pancreas tumors, grwon in SCID mice. ï Species? Human and maybe mouse (ingrowth of mouce cells into the tumor) ï Cell line? ï Tissue? Tumors 3. How did you fix the samples? Acetone Ethanol, methanol Acetone: Acetone Paraformaldehyde Other 4. Did you apply antigen retrieval step? No >ï Enzymatic method >ï Heat mediated technique >ï Other 5. How did you block the unspecific binding sites? 3% bovine serum albumine 6. Primary antibody Species: Human, mouse, rat Dilutions: 1:100, 1:1000 Incubation time: over night at 4 degrees. Washes: 3x5 minutes ï Specification (in which species was it raised against)? ï At what dilution(s) have you tested this antibody? ï Incubation time, wash steps (multiple short washes are more effective than fewer longer wash steps)? 7. Secondary antibody ï What secondary antibody are you using? ï Specification (in which species was it raised against)? ï At what dilution(s) have you tested this antibody? ï Incubation, wash steps? ï Do you know whether the problems you are experiencing come from the >secondary? ï What detection method are you using? Secondary: Alexa goat anti-mouse, HCA (highly cross adsorbed); Molecular Probes. Dilutions: 1:1000 Incubation: 1 hour room temp. Wash: 3x10 min I daubt that the problems are due to the secondary as I use these type of secondary antibodies every week. Detection: immunoflourescence 8. Background staining ï Please provide an image of your staining It is included. 9. Which detection system did you use? Belive I have answered this question in panel 7. 10. Did you apply positive and negative controls along with the samples? Please specify. I always try primary alone, and secondary alone. 11. Optimization attempts ï How many times have you tried the IHC? ï Do you obtain the same results every time? ï What steps have you altered? Times with this antibody: 2 times Yes, the same result but at two different concentrations, which means weaker signal/background with a more diluted primary antibody. I have altered the dilutions. My positive control is the double staining of CD31 in both cases. I also include a picture of FGFR-1 and CD31 staining of FGFR-1 from Santa Cruz. Finally, we would like to reassure you that Abcam policy dictates that if a product does not performed as stated on the datasheet; we will offer a full reimbursement or provide a replacement of equivalent value. We are looking forward to hearing from you soon.

      Read More

      Abcam community

      Verified customer

      Asked on Mar 01 2004

      Answer

      Thank you for your patience. I have been discussing this complaint with my colleagues. Unfortunately, we do not really know why this antibody did not perform well for you. We haven't had any complaints about this one. In fact, most of our customers for this antibody use it for immunohistochemistry. A couple of things stand out in your protocol: (1) You pretreat the tissue sections with bovine serum albumin to block non-specific binding. Because BSA doesn't contain any immunoglobulin that can occupy Fc receptors that might be present on cells in tissues, we always recommend blocking tissue sections with an unrelated normal serum, such as goat or rabbit. We realize, though, that you feel that blocking with BSA worked well for the Santa Cruz antibody, so you did probably not inclined to try blocking with normal serum. (2) It was difficult to compare the photos of the tissue staining that you provided because each photo appeared to be a different tissue section than the other photos. Where your felt that you saw very high background staining (with Abcam antibody at 1:100), we think you used too high a concentration of primary antibody. According to our records, the batch that you purchased was at a concentration of 1.65 mg/ml. Therefore, a 1:100 dilution of this would give a working solution of 16.5 ug/ml. This is a rather high antibody concentration for IHC. Most of our antibodies work in the range of 3-5 ug/ml. Of course, the 1:1000 dilution gives a working solution of 1.65 ug/ml, and this might be too low. We could send you a replacement vial, but it would be the same lot as what you already received (it is the only lot we have at this time), and we would guess that you wouldn't be eager to try this one again. Perhaps the most expedient solution is for you a credit note or refund. Please do let me know what you would like to do.

      Read More

      Abcam Scientific Support

      Answered on Mar 11 2004

      Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
      For licensing inquiries, please contact partnerships@abcam.com

      技術情報や製品情報をメールで受け取る 登録
      製品・研究分野別
      • 癌
      • 循環器
      • 細胞生物学
      • 発生
      • エピジェネティクス&核内情報
      • 免疫学
      • メタボリズム
      • 感染症
      • ニューロサイエンス
      • シグナル伝達
      • ステムセル
      製品・タイプ別
      • 一次抗体
      • 二次抗体
      • バイオケミカルズ
      • アイソタイプ・コントロール
      • マルチカラー・セレクター
      • キット
      • ローディング・コントロール
      • ライゼート
      • ペプチド
      • タンパク質
      • スライド
      • タグ抗体・細胞マーカー
      • その他試薬
      サービス&サポート
      • サポート
      • よくあるお問い合わせ
      • プロトコール&トラブルシュート
      • ご購入に関して
      • お問い合わせフォーム
      • トレーニング
      • ターゲット別に見る
      アブカムについて
      • 企業ウェブサイト
      • 投資家の皆様へ
      • 企業情報
      • 採用情報
      • アブカムについて
      イベント
      • 展示会
      • カンファレンス
      ブログ

      ブログを読む

      International websites
      • abcam.com
      • abcam.cn

      Join with us

      • LinkedIn
      • facebook
      • Twitter
      • YouTube
      • Terms of sale
      • Website terms of use
      • Cookie policy
      • Privacy policy
      • Legal
      © 1998-2021 Abcam plc. All rights reserved.